Alfred Sandrock, President and CEO at Voyager Therapeutics, Inc. (VYGR), sold 26,066 shares at $7.46 ($194K) on 2024-02-21, disclosed to the SEC on 2024-02-22.
Open-market sale of $194k VYGR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.46 | 13,033 | $97K | 50.0% |
| 2 | $7.46 | 13,033 | $97K | 50.0% |
| Total | $7.46 avg | 26,066 | $194K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |